The World Health Organization (WHO) on Monday recommended a new anti-malaria vaccine for children, a move that could offer countries a cheaper and more readily available option than the world’s first shot against the parasitic disease.
The R21/Matrix-M vaccine, developed by Britain’s Oxford University, can be used to curb the life-threatening illness spread to humans by mosquitoes, the WHO said, stating that “both vaccines are shown to be safe and effective in preventing malaria in children and, when implemented broadly, are expected to have high public health impact.”
